Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.

Duchini G, Itin P, Arnold A.

Adv Skin Wound Care. 2011 May;24(5):217-20. doi: 10.1097/01.ASW.0000397898.56121.3f.

PMID:
21505282
2.

Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment.

Del Giacco SR, Firinu D, Lorrai MM, Serusi L, Meleddu R, Barca MP, Peralta M, Manconi PE.

Acta Derm Venereol. 2012 Jul;92(4):439-40. doi: 10.2340/00015555-1301. No abstract available.

3.

[Infliximab for a girl with refractory pyoderma gangrenosum].

Nozawa T, Hara R, Kinoshita J, Sano F, Miyamae T, Imagawa T, Mori M, Hirokado M, Takahashi K, Inayama Y, Yokota S.

Nihon Rinsho Meneki Gakkai Kaishi. 2008 Dec;31(6):454-9. Japanese.

4.

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.

Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR.

Am J Gastroenterol. 2003 Aug;98(8):1821-6.

PMID:
12907338
5.

Pyoderma gangrenosum.

Conrad C, Trüeb RM.

J Dtsch Dermatol Ges. 2005 May;3(5):334-42. Review.

PMID:
16372799
6.

Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.

López San Román A, Bermejo F, Aldanondo I, Carrera E, Boixeda D, Muñoz Zato E.

Rev Esp Enferm Dig. 2004 Jun;96(6):420-2; 422-4. English, Spanish.

PMID:
15230672
7.

Systemic pyoderma gangrenosum responding to infliximab and adalimumab.

Hubbard VG, Friedmann AC, Goldsmith P.

Br J Dermatol. 2005 May;152(5):1059-61.

PMID:
15888172
8.

[Pyoderma gangrenosum: case series].

Richetta AG, Maiani E, Carboni V, Carlomagno V, Cimillo M, Mattozzi C, Calvieri S.

Clin Ter. 2007 Jul-Aug;158(4):325-9. Italian.

PMID:
17953284
9.

[Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].

García-Rabasco AE, Esteve-Martínez A, Zaragoza-Ninet V, Sánchez-Carazo JL, Alegre-de-Miquel V.

Actas Dermosifiliogr. 2010 Oct;101(8):717-21. Review. Spanish.

PMID:
20965015
10.

[Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].

Nybaek H, Jemec GB.

Ugeskr Laeger. 2005 Aug 8;167(32):2920-1. Danish. No abstract available.

PMID:
16109221
11.

Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.

Juillerat P, Christen-Zäch S, Troillet FX, Gallot-Lavallée S, Pannizzon RG, Michetti P.

Dermatology. 2007;215(3):245-51. Review.

PMID:
17823524
12.

Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.

Kouklakis G, Moschos J, Leontiadis GI, Kadis S, Mpoumponaris A, Molyvas E, Minopoulos GI.

Rom J Gastroenterol. 2005 Dec;14(4):401-3.

13.

Pyoderma gangrenosum associated with hidradenitis suppurativa.

Ah-Weng A, Langtry JA, Velangi S, Evans CD, Douglas WS.

Clin Exp Dermatol. 2005 Nov;30(6):669-71.

PMID:
16197385
14.

Infliximab for peristomal pyoderma gangrenosum.

Mimouni D, Anhalt GJ, Kouba DJ, Nousari HC.

Br J Dermatol. 2003 Apr;148(4):813-6.

PMID:
12752145
15.

Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.

Cocco A, Angelucci E, Viscido A, Caprilli R.

Inflamm Bowel Dis. 2007 Oct;13(10):1317-9. No abstract available.

PMID:
17508417
16.

Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.

Ueda M, Katoh M, Tanizaki H, Tanioka M, Matsumura Y, Miyachi Y.

Dermatol Online J. 2012 Jan 15;18(1):12.

17.

Pustular pyoderma gangrenosum.

Shankar S, Sterling JC, Rytina E.

Clin Exp Dermatol. 2003 Nov;28(6):600-3.

PMID:
14616824
18.

Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab.

Swale VJ, Saha M, Kapur N, Hoffbrand AV, Rustin MH.

Clin Exp Dermatol. 2005 Mar;30(2):134-6.

PMID:
15725238
19.

Treatment of pyoderma gangrenosum with methotrexate.

Teitel AD.

Cutis. 1996 May;57(5):326-8.

PMID:
8726713
20.

Pyoderma gangrenosum--rebel without a cure?

Jacob SE, Weisman RS, Kerdel FA.

Int J Dermatol. 2008 Feb;47(2):192-4. doi: 10.1111/j.1365-4632.2008.03412.x.

PMID:
18211497
Items per page

Supplemental Content

Support Center